Tapan Kadia, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Glycomimetics
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Astex
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Regeneron
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Agios
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Rigel
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Daichi Sankyo
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Liberum
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sanofi
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Servier
    Date added:
    09/06/2023
    Date updated:
    09/06/2023

Pages

Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice